ClinConnect ClinConnect Logo
Search / Trial NCT01914016

Functional Electrical Stimulation for People With Multiple Sclerosis Who Experience Foot Drop

Launched by QUEEN MARGARET UNIVERSITY · Jul 31, 2013

Trial Information

Current as of July 21, 2025

Completed

Keywords

ClinConnect Summary

Participants People with MS (aged 18 or over) who are assessed for their suitability for FES to treat foot-drop at Slateford Medical Centre are eligible for participation in this study.

For this feasibility study we aim to recruit at least 10 participants.

Recruitment Eligible patients will be given an information sheet by their physiotherapist who will introduce the study at their initial appointment. A second appointment is made to fit the FES unit and if the patient is willing to consider taking part in the study, informed consent is taken.

Data collection To record the degree of foot...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • People with MS (aged 18-80) who are assessed for their suitability for FES to treat foot-drop between September 2013 and March 2014 at Slateford Medical Centre are eligible for participation in this study
  • Exclusion Criteria:
  • Patients with fixed ankle deformities, who are allergic to tape and who are unable to walk for at least for two minutes (with or without walking aids) will be excluded.
  • Patients who experienced a relapse or any trauma affecting their walking between the first fitting appointment and the follow-up appointment will also be excluded from the study.

About Queen Margaret University

Queen Margaret University (QMU) is a renowned institution dedicated to advancing health and social care through innovative research and academic excellence. With a strong emphasis on interdisciplinary collaboration, QMU engages in clinical trials that aim to enhance patient outcomes and inform evidence-based practices. The university’s commitment to addressing real-world health challenges is reflected in its partnerships with healthcare providers and stakeholders, ensuring that research findings translate effectively into practice. Through its robust ethical standards and focus on participant welfare, QMU is poised to contribute significantly to the field of clinical research.

Locations

Edinburgh, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Marietta L van der Linden, PhD

Principal Investigator

Queen Margaret University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials